BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioWa, Inc. 

Corporate Office
212 Carnegie Center, Suite 101
Princeton  New Jersey  08540  U.S.A.
Phone: 609-580-7500 Fax: 609-919-1108


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Lonza Inc. and BioWa Sign License Agreements with FivePrime Therapeutics, Inc. for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development 6/13/2012 10:25:54 AM    More...
arGEN-X Announces Non-exclusive License with BioWa for Potelligent® Technology 7/26/2011 11:43:41 AM    More...
arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology 7/26/2011 9:43:21 AM    More...
ImmunoCellular Therapeutics, Ltd and BioWa Announce License for the Research and Development of Therapeutic Antibodies in Cancer 6/2/2011 10:14:36 AM    More...
Oxford BioTherapeutics Licenses BioWa's POTELLIGENT(R) Technology for the Research and Development of its Therapeutic Antibodies in Cancer 4/6/2011 7:40:13 AM    More...
KaloBios Pharmaceuticals, Inc. Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Humaneered(TM) Antibodies 2/8/2011 9:06:25 AM    More...
Daiichi Sankyo, Inc. (D4S.F) Selects POTELLIGENT(R) CHOK1SV Cell Line for the Research, Development and Manufacture of Recombinant Antibodies 7/26/2010 10:24:25 AM    More...
BioWa Announces Expansion of Licenses to GlaxoSmithKline (GSK) 6/23/2010 10:02:25 AM    More...
BioWa and NKT Therapeutics Inc. Announce Licensing of BioWa's POTELLIGENT(R) Technology For Use in Antibody Research and Development 10/21/2009 9:34:57 AM    More...
BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA (MKGAF.PK) 7/15/2009 8:48:45 AM    More...
1234